Cannabis Coffee & Tea Pod Company Ltd. – Trademark Portfolio
Entity Type: 99
Cannabis Coffee & Tea Pod Company Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. The portfolio also extends into Class 30 (Staple Foods) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include BREW BUDZ. The owner is based in Vaughan, Ontario.
3280 Langstaff Road, Unit 1
Vaughan, Ontario L4K4Z8 , CA
Showing of trademarks Trademarks
Trademark Classifications
Cannabis Coffee & Tea Pod Company Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does Cannabis Coffee & Tea Pod Company Ltd. have?
Cannabis Coffee & Tea Pod Company Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Cannabis Coffee & Tea Pod Company Ltd. file in?
Cannabis Coffee & Tea Pod Company Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Cannabis Coffee & Tea Pod Company Ltd.'s most well-known trademarks?
Cannabis Coffee & Tea Pod Company Ltd.'s registered trademark portfolio includes well-known marks such as BREW BUDZ. These are among 1 currently registered trademark in the portfolio.
What is Cannabis Coffee & Tea Pod Company Ltd.'s trademark registration success rate?
Cannabis Coffee & Tea Pod Company Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.